Ruth Marcus, a longtime columnist at The Post, said its publisher refused to run her critique of the new focus for the paper’s opinion section.
Related Posts
Robert F. Kennedy Jr.’s Billion-Dollar Hit to Big Pharma
Donald Trump’s choice to run the Department of Health and Human Services spooked investors who worry what Kennedy would do.
Stocks Tumble in Asia as Tech Investors Pull Back
Nvidia, the American semiconductor giant, announced that it had been blocked by the Trump administration from selling chips to China without a license.
FDA Bans Red Dye 3 in Foods, Linking It to Cancer in Rats
Consumer and food safety groups have long urged the agency to revoke the use of this dye and others. The F.D.A. says there still is […]